|1||NCT01327248||Completed||Clinical Status and Bronchial Inflammation in Patients With Bronchiolitis Obliterans||
||40||All||6 Years to 25 Years (Child, Adult)||NCT01327248||FRA-BO||Frabo||May 2011||May 2012||June 2012||April 1, 2011||June 27, 2012||
|Safety Study of Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS)||
||Other / Industry||
||30||All||18 Years and older (Adult, Senior)||NCT01469364||Pro00030559
Gilead Sciences, Inc
|AZLI||March 2013||March 2015||April 2015||November 10, 2011||January 29, 2016||November 26, 2015||
† Study has passed its completion date and status has not been verified in more than two years.